Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (5515)	10/17/1998 3:37:00 PM
From: nord	of 6136

add imnr earnings and the potential for more deals coming for agph Sorry John I have a penchant for runnon sentences that most get use to but to the unfamiliar they are misleading. I Also own IMNR and know that earnings aren't yet on the horizon but the next data points from fred valentine are. i was just mentioning the positives in addition to midcap 400 listing, earnings which i feel will meet street numbers and the potential for nice data from imnr arm. btw i think the study design the current upront antivirals are not first line and i think newer data combining sustiva viracept and combivir would be a nice dual arm to add imnr to one side of...my bet the numbers would be pretty awesome norden

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next